Tag: immunotherapy research award

Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Published on by World Science Awards

Dr. Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Department of Bacterial Diseases of Animals, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Dr. Alireza Dehnad is an accomplished microbiologist and biotechnology researcher whose career spans over twenty-five years of impactful scientific work in veterinary microbiology, microbial biotechnology, and infectious disease research. With 88 Scopus-indexed publications, 2,503 citations, and an h-index of 27, he has demonstrated a consistent record of scholarly excellence, research productivity, and international recognition. His work encompasses diverse domains including microbial bioprocessing, secondary metabolite discovery, nanobiotechnology, antibiotic-producing Actinomycetes, viral and bacterial disease epidemiology, probiotics, wound healing applications, biopolymers for drug delivery, and microbial bioremediation. A major strength of Dr. Dehnad’s scientific career is his ability to bridge fundamental microbiology with translational biotechnology, generating research outputs that extend from laboratory innovation to real-world applications in human health, veterinary medicine, agriculture, and industrial biotechnology. He has contributed to notable advances in green nanoparticle synthesis, microbial metabolite-based therapeutics, pathogen surveillance, and probiotic industrialization. His experience supervising over 100 postgraduate theses and lecturing internationally reflects strong academic leadership, mentorship capacity, and global collaboration. Dr. Dehnad has earned prestigious national awards in recognition of his research contributions, including honors from the Razi Vaccine and Serum Research Institute and the Agricultural Biotechnology Research Institute. His leadership roles across scientific institutions, advisory committees, and biotechnology laboratories demonstrate institutional influence and commitment to advancing regional and national scientific infrastructure. While his research output is internationally visible and diverse, areas for continued development include expanding multi-center global collaborations, strengthening cross-disciplinary publications in high-impact journals, and increasing patent commercialization and industrial partnerships to further translate research outcomes into market-ready solutions.

Profiles: Scopus | ORCID

Featured Publications

Mahmoudi, F., Baradaran, B., Dehnad, A., Shanehbandi, D., Mohamed Khosroshahi, L., & Aghapour, M. (2016). The immunomodulatory activity of secondary metabolites isolated from Streptomyces calvus on human peripheral blood mononuclear cells. British Journal of Biomedical Science.

Khandan Nasab, N., Dehnad, A. R., Salimizand, H., Taherzadeh, D., Prakash, D., Verma, K. D., & Darroudi, M. (2016). Zinc selenide nanoparticles (ZnSe-NPs): Green synthesis and investigation of their cytotoxicity effects. Ceramics International.

Dehnad, A., Hamedi, J., Derakhshan-Khadivi, F., & Abusov, R. (2015). Green synthesis of gold nanoparticles by a metal resistant Arthrobacter nitroguajacolicus isolated from gold mine. IEEE Transactions on Nanobioscience.

Sadighbayan, K., Dehnad, A., Monadi, A., Mobaiyen, H., & Sadighbayan, D. (2013). An evaluation about the role of microorganisms isolated from the soil in the biological removal of toxic petroleum pollutants. Journal of Environmental Studies.

Sadigh-Eteghad, S., Dehnad, A., Mahmodi, J., Hoseyni, H., Khalili, I., & Razmaray II, N. (2013). Healing potential of a Streptomyces sp. secondary metabolite, SEM-1-111, on experimental full-thickness excision cutaneous wounds in Wistar rats. Clinical and Experimental Dermatology.

Himanshi Yaduvanshi | Onco-Immunology | Best Researcher Award

Published on by World Science Awards

Dr. Himanshi Yaduvanshi | Onco-Immunology | Best Researcher Award

Springer Nature | India

Dr. Himanshi Yaduvanshi is a PhD-trained life sciences researcher with strong expertise in oncology, immunology, and metabolic disorders, specializing in the interplay between glucose and lipid metabolism and cancer progression. Her research contributions span mechanistic studies in melanoma, breast cancer, and colon cancer, with a particular focus on metabolic reprogramming, macrophage phenotypic switching in obesity-linked tumor growth, and therapeutic modulation of cholesterol pathways. She has published several peer-reviewed research articles in respected journals such as Cancer Research, Cancer Metabolism, Molecular Cell Research, and Journal of Biosciences, in addition to contributing to preprints and collaborative manuscripts currently in preparation. Her work is further strengthened by involvement in an Indian patent on a novel anticancer therapeutic combination, demonstrating her commitment to translational innovation. Dr. Yaduvanshi’s technical proficiency encompasses flow cytometry, confocal microscopy, in vivo tumor models, metabolic assays using Seahorse technology, immunophenotyping, molecular cloning, qPCR, immunoblotting, and proteomics workflows. Her research background is distinguished by effective collaboration across multidisciplinary teams at the National Centre for Cell Science (NCCS), where she led experimental design, troubleshooting, and data analysis for complex, multi-lab projects. She has participated in national and international scientific platforms, presenting her work at the International Union of Immunological Societies (IUIS) Conference, CMBC Conference, and Immuno-Oncology Society of India (I-OSI), earning recognition for both poster and oral presentations. Beyond academic research, Dr. Yaduvanshi contributes to scientific communication and industry engagement through her roles as Technical Sales Manager at Bio Bench Solutions and Associate Editor with Springer Nature, where she ensures the quality and integrity of scientific protocols. Her work collectively supports societal impact by advancing understanding of cancer metabolism and informing the development of more effective therapeutic strategies. With a strong record of research excellence, innovation, and interdisciplinary collaboration, Dr. Yaduvanshi continues to contribute meaningfully to global biomedical science.

Profile: ORCID

Featured Publications

  1. Athavale, D., Yaduvanshi, H., Bhati, F. K., Mayengbam, S. S., More, T., Rapole, S., & Bhat, M. K. (2024). Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment.
  2. Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023). Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells. Cancer & Metabolism, 11.
  3. Singh, A., Mayengbam, S. S., Yaduvanshi, H., Wani, M. R., & Bhat, M. K. (2022). Obesity programs macrophages to support cancer progression. Cancer Research, 82.